Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer

Fig. 4

The output of probabilistic sensitivity analysis. Notes: In the incremental cost-effectiveness scatter plot, each dot represents one output. The red circle is the 95% confidence ellipse. The black dashed line represents the WTP threshold; In the cost-effectiveness acceptable curve, the y-axis indicates the likelihood that a regimen is cost-effective across the willingness-to-pay threshold (x-axis). The red dashed line represents the WTP threshold. The monetary unit of the WTP threshold is the United States dollar

Back to article page